Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. Faces Risks with Obesity Drug, Causing Stock to Slip

November 13, 2024
Amgen Inc. (NASDAQ: AMGN) recently faced a setback as safety concerns emerged regarding their obesity candidate drug. This update caused the company's stock to slip. Investment firm Cantor has cited these concerns, raising questions about the safety profile of the drug. However, Amgen's problems go beyond this issue, as their weak profit performance has also impacted their stock value. Investors are urged to seek professional advice from Stocks Prognosis to make informed decisions on the future movement of Amgen's stock.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNJuly 30, 2025Amgen Inc. NASDAQ:AMGN Shares Unloaded by Rep. Jefferson Shreve  ~1 min.

Recently, Representative Jefferson Shreve unloaded a significant number of Amgen Inc. (NASDAQ:AMGN) shares....


AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....


AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....


AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....


AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....


AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....


AMGNMarch 10, 2025AMGEN INC. Hits Price Target Forecast with 20.7% Profit: A Success Story for QuantWave  ~1 min.

AMGEN INC. has recently reached the price target forecast set by QuantWave, resulting in a significant profit of 20.7% for investors who followed the predictive signal....


AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....


AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....


AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....


AMDJanuary 13, 2025Advanced Micro Devices Inc. AMD: A Game-Changing Partnership with Dell  ~2 min.

Advanced Micro Devices Inc. (AMD), the leading semiconductor company, has announced a ground-breaking partnership with Dell....


NEMJanuary 7, 2025Newmont Corporation NEM Stock Declines While Market Improves: Investors Advised to Seek Professional Guidance  ~1 min.

Newmont Corporation, a leading gold mining company, has experienced a decline in its stock price amidst an overall improvement in the market....


ETH-USDJanuary 1, 2025ETHUSD buying the dips after Elliott Wave double three  ~2 min.

Ethereum (ETH) has been experiencing a series of dips in its price recently, but experts believe that this is a temporary setback....


LLYNovember 8, 2024Eli Lilly and Company LLY's Latest EPS Miss Raises Concerns - Experts Recommend Seeking Professional Stock Prognosis Advice  ~1 min.

Eli Lilly and Company, a renowned pharmaceutical corporation, recently reported an EPS miss of 31%....


MUJanuary 10, 2025Micron Technology Inc. NASDAQ:MU: Expands Crucial Lineup with High-Speed SSDs and DRAM Upgrades for Gaming AI and Professional Use  ~2 min.

Micron Technology Inc., a leading global semiconductor company, has announced its expansion of the Crucial lineup with high-speed SSDs and DRAM upgrades....